Literature DB >> 29140881

PDGFB Rearrangements in Dermatofibrosarcoma Protuberans of the Vulva: A Study of 11 Cases Including Myxoid and Fibrosarcomatous Variants.

Khadijeh Jahanseir1, Deyin Xing, Patricia T Greipp, William R Sukov, Gary L Keeney, Brooke E Howitt, J Kenneth Schoolmeester.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a low-grade fibroblastic sarcoma that tends to arise in young to middle age adults and involve the trunk and proximal extremities. Rare examples of vulvar DFSP have been reported, including myxoid, myoid, and fibrosarcomatous variants, but detection of the characteristic t(17;22)(q22;q13) that produces COL1A1-PDGFB gene fusion has not been evaluated in a large series of primary vulvar tumors. The clinical, morphologic, immunohistochemical, and molecular cytogenetic features of 11 cases were examined. Patient age ranged from 29 to 75 yr (mean, 46 yr; median, 43 yr). Seven tumors were purely classic DFSP, 1 was purely myxoid DFSP and the remaining 3 had varying quantities of fibrosarcomatous DFSP. All cases of classic DFSP had diffuse expression of CD34 and low-level p53 immunoreactivity. Myxoid variants had strong, but reduced expression of CD34. Fibrosarcomatous DFSP showed focal CD34 expression and increased p53 reactivity. Nine of 11 tumors (82%) had rearrangement of PDGFB by fluorescence in situ hybridization. The 2 nonrearranged tumors were a classic DFSP and a myxoid DFSP with fibrosarcomatous transformation. Follow-up was available for 9 patients (82%) and ranged from 1 to 108 mo (mean, 30 mo; median, 21 mo). Eight patients had tumors with positive margins, one of which developed local recurrence after no further therapy. No patient developed metastasis. The high frequency of PDGFB rearrangement in vulvar DFSP provides a useful exploit in diagnostically challenging cases and genetic evidence of probable clinical response to targeted therapeutics in cases of locally advanced or metastatic tumors.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29140881      PMCID: PMC5951727          DOI: 10.1097/PGP.0000000000000472

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  40 in total

1.  Dermatofibrosarcoma protuberans: A clinicopathologic analysis of patients treated and followed at a single institution.

Authors:  W B Bowne; C R Antonescu; D H Leung; S C Katz; W G Hawkins; J M Woodruff; M F Brennan; J J Lewis
Journal:  Cancer       Date:  2000-06-15       Impact factor: 6.860

Review 2.  Dermatofibrosarcoma protuberans of the vulva: clinicopathologic and immunohistochemical analysis of four cases, one with fibrosarcomatous change, and review of the literature.

Authors:  R P Ghorbani; A Malpica; A G Ayala
Journal:  Int J Gynecol Pathol       Date:  1999-10       Impact factor: 2.762

3.  Clinical, histopathological, dermatoscopic and digital microscopic features of dermatofibroma: a retrospective analysis of 200 lesions.

Authors:  E Şenel; Y Yuyucu Karabulut; S Doğruer Şenel
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-03-19       Impact factor: 6.166

4.  Deregulation of the platelet-derived growth factor B-chain gene via fusion with collagen gene COL1A1 in dermatofibrosarcoma protuberans and giant-cell fibroblastoma.

Authors:  M P Simon; F Pedeutour; N Sirvent; J Grosgeorge; F Minoletti; J M Coindre; M J Terrier-Lacombe; N Mandahl; R D Craver; N Blin; G Sozzi; C Turc-Carel; K P O'Brien; D Kedra; I Fransson; C Guilbaud; J P Dumanski
Journal:  Nat Genet       Date:  1997-01       Impact factor: 38.330

5.  Aggressive angiomyxoma of pelvic parts exhibits oestrogen and progesterone receptor positivity.

Authors:  W G McCluggage; A Patterson; P Maxwell
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

6.  Dermatofibrosarcoma protuberans of the vulva and groin: detection of COL1A1-PDGFB fusion transcripts by RT-PCR.

Authors:  Neriman Gökden; Louis P Dehner; Xiaopei Zhu; John D Pfeifer
Journal:  J Cutan Pathol       Date:  2003-03       Impact factor: 1.587

7.  Pigmented dermatofibrosarcoma protuberans (Bednar tumor). A pathologic, ultrastructural, and immunohistochemical study.

Authors:  W B Dupree; J M Langloss; S W Weiss
Journal:  Am J Surg Pathol       Date:  1985-09       Impact factor: 6.394

8.  Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.

Authors:  Julie D R Reimann; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2007-09       Impact factor: 6.394

9.  Desmoplastic malignant melanoma. An immunocytochemical study of 25 cases.

Authors:  A Anstey; R Cerio; N Ramnarain; G Orchard; N Smith; E W Jones
Journal:  Am J Dermatopathol       Date:  1994-02       Impact factor: 1.533

10.  CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans.

Authors:  V G Prieto; J A Reed; C R Shea
Journal:  J Cutan Pathol       Date:  1994-08       Impact factor: 1.587

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.